• ECL Chemiluminescent Substrate Kit: Hypersensitive Detection

  2026-06-11

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) enables ultrasensitive, HRP-based chemiluminescent detection of proteins on nitrocellulose or PVDF membranes. This kit supports low picogram-level sensitivity, long signal duration, and minimal background, making it highly effective for immunoblotting detection of low-abundance proteins.

• TG003: Cdc2-like Kinase Inhibitor for Alternative Splicing R

  2026-06-10

  TG003 is a nanomolar-potency Cdc2-like kinase inhibitor that enables precise modulation of alternative splicing and splice site selection. It is widely used in research on platinum resistance mechanisms and exon-skipping therapies. Benchmark studies highlight its specificity, reproducibility, and utility in both cellular and animal models.

• Structural Insights into TRPM3 Modulation by Neurosteroids a

  2026-06-10

  This study reveals high-resolution cryo-EM structures of the TRPM3 ion channel in complex with neurosteroids and the anticonvulsant primidone, providing a molecular basis for TRPM3 regulation. The findings clarify how disease mutations and pharmacological agents modulate channel gating, offering pathways for developing targeted therapies for pain and neurodevelopmental disorders.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-06-09

  Xiao et al. (2024) uncover how 25-hydroxycholesterol (25HC), produced by CH25H, accumulates in lysosomes of tumor-associated macrophages, activating AMPK and reprogramming metabolism to promote immunosuppression. These findings establish CH25H as a metabolic checkpoint and suggest new strategies for modulating tumor immunity.

• iRhom2 Modulates Odorant Receptor Adaptation in Olfactory Ne

  2026-06-09

  Azzopardi et al. (2024) uncover a specialized role for iRhom2 in olfactory sensory neurons (OSNs), demonstrating its involvement in the regulation and adaptation of odorant receptor gene expression. Their integrative approach reveals an activity-dependent feedback loop linking olfactory stimuli, iRhom2/ADAM17 signaling, and transcriptional changes in the olfactory system.

• MK-2206 dihydrochloride: Applied Strategies in Akt Pathway M

  2026-06-08

  MK-2206 dihydrochloride empowers researchers to dissect PI3K/Akt/mTOR signaling with precision, enabling advanced apoptosis and persistence assays across cancer and infectious disease models. This guide delivers actionable protocols, troubleshooting insights, and applied innovations from the latest host-pathogen research.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Surface Ass

  2026-06-08

  Sulfo-NHS-Biotin stands out for its water solubility and exclusive cell surface specificity, empowering researchers to achieve high-fidelity, amine-selective biotinylation without organic solvents. This guide explores advanced workflows, protocol optimizations, and troubleshooting strategies that maximize the reagent’s potential in proteomics, immunoprecipitation, and interaction mapping.

• O-Propargyl-Puromycin: Bridging Mitochondrial Integrity and

  2026-06-07

  This thought-leadership article explores how O-propargyl-puromycin (OPP) empowers translational researchers to dissect the mechanistic interplay between mitochondrial integrity, protein synthesis, and adaptive immunity. By integrating new mechanistic insights from recent immunology research with practical workflow guidance and a forward-looking perspective, the article advances beyond standard product pages to provide actionable, evidence-based strategies for translational research.

• Cy5 NHS ester(Et): Practical Guide for Biomolecule Labeling

  2026-06-06

  Cy5 NHS ester(Et) enables water-soluble, covalent fluorescent labeling of proteins and other biomolecules by targeting primary amines. It is particularly useful for immunofluorescence, flow cytometry, and microscopy workflows that require high labeling efficiency and minimal background. Ethanol-based protocols and long-term storage of dye solutions are not recommended for this reagent.

• Allosteric PDK4 Inhibitors: A New Avenue for Metabolic Disea

  2026-06-05

  The referenced study identifies a novel class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c demonstrating potent activity in vitro and in vivo. These findings provide a robust scaffold for metabolic disease drug development and reveal new intervention points for conditions such as diabetes, allergy, and cancer.

• Targeting CLK2 to Overcome Platinum Resistance in Ovarian Ca

  2026-06-05

  The referenced study identifies Cdc2-like kinase 2 (CLK2) as a key driver of platinum resistance in ovarian cancer through its phosphorylation of BRCA1 and enhancement of DNA damage repair. These findings open new avenues for alternative splicing modulation and targeted therapy in resistant ovarian tumors.

• Angiotensin 1/2 (2-7) Peptide: Advanced Insights for RAS and

  2026-06-04

  Explore the distinct biochemical and translational research applications of Angiotensin 1/2 (2-7), a vasoconstrictor peptide critical for blood pressure regulation and emerging viral pathogenesis studies. Gain unique protocol guidance and comparative analysis not found in standard reviews.

• Baicalein: Applied Protocols for Cancer & Inflammation Resea

  2026-06-04

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) stands out as a precision tool for dissecting cancer cell proliferation and inflammation pathways via 12-LOX inhibition. This article delivers hands-on experimental workflows, troubleshooting insights, and critical contrasts with emerging neuroprotective strategies, helping researchers maximize reproducibility and translational value.

• Cannabidiol Mitigates Orofacial Inflammatory Pain and Emotio

  2026-06-03

  This study demonstrates that cannabidiol (CBD) robustly attenuates both the sensory and affective components of orofacial inflammatory pain in mice through coordinated modulation of endocannabinoid and serotonergic pathways. The findings support CBD's translational potential for comprehensive management of pain and its comorbid emotional disturbances.

• Rotavirus Infection Disrupts Nrf2-Dependent Redox Defense Pa

  2026-06-03

  This study reveals that progressive rotavirus infection leads to a marked downregulation of the Nrf2 transcription factor and its antioxidant gene targets in host cells. By dissecting the timeline and regulatory mechanisms of Nrf2 suppression, the findings clarify viral strategies to subvert cellular redox homeostasis and suggest new directions for therapeutic intervention.

8556 records 9/571 page Previous Next First page 上5页 678910 下5页 Last page